Clinical Trial Update: A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy [Phase 4]

View source ↗

Summary

This Phase 4 pragmatic, randomized multicenter trial compares a single dose of pegfilgrastim to five daily doses of filgrastim in early-stage breast cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Early-stage Breast Cancer | Phase 4 | Status: COMPLETED